First UK clinical study on PTH 1-84

The Uk's first clinical study into the use of parathyroid hormone (PTH 1-84) for the treatment of Hypoparathyroidism, as part of a global study sponsored by NPS Pharmaceuticals,Inc. is now open in Liverpool and is recruiting UK patients. For more information please click here

FAQ's on Clinical Trials

A downloadable and printable PDF booklet on the questions frequently asked by those thinking of joining a clinical trial has been produced by the European Genetic Alliances Network (EGAN) and Roche.

Other trials which are currently recruiting:

PTH 1-34 trial , NIH, Maryland, USA

The purposes of this 5 year  study are to better understand the effects of hypoparathyroidism on the skeleton and to evaluate the effects of parathyroid hormone replacement therapy on bone in hypoparathyroidism. To read more please click here